Investigated the causes of missed miscarriage but still no answers? Don’t just focus on chromosomes—this “medication history over the past year” may be what you’ve overlooked.

Still No Answer After Investigating the Causes of Missed Miscarriage? Don’t Focus Only on Chromosomes—This “Past-Year Medication History” May Have Been Overlooked

After experiencing a missed miscarriage, embryonic chromosomal abnormalities, or undergoing several rounds of IVF without achieving the desired result, many families enter round after round of testing: both partners’ chromosomes, immunity, coagulation function, thyroid and other endocrine markers, uterine cavity environment, embryo status… Almost every test they can think of has been done, yet the final result remains “no clear abnormality found.”

In this situation, there is another easily overlooked detail—what medications were actually taken in the period before trying to conceive?

Medications are not the leading cause of recurrent missed miscarriage, and taking a certain drug in the past does not automatically mean it caused embryonic abnormalities or miscarriage. However, after common factors have been systematically evaluated, reviewing both partners’ recent prescription drugs, long-term medications, and even short-term medications used in the past can indeed be valuable. In particular, some medications carry clear reproductive risks, and the required contraception period after stopping them is significantly longer than that of ordinary drugs. Two worth noting are ribavirin and statin lipid-lowering drugs. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

For families preparing for natural conception, or planning IVF, Thailand third-generation IVF, fertility treatment abroad, or cross-border childbirth, preconception assessment should not look only at today’s AMH, follicles, and endometrium. Sometimes it is necessary to look back several months and review the complete medication record.

I. Ribavirin: Feeling Fine After Taking the Medication Does Not Mean You Are Immediately Ready to Conceive

Ribavirin is an antiviral medication. Unlike many drugs that are cleared within a few days after stopping, it has an important characteristic: it can enter red blood cells and remain in the body for a long time. Therefore, when pregnancy and preconception are involved, its management has always been approached cautiously.

Many people easily fall into a misconception: the drug has been stopped, the cold or infection symptoms have resolved, and there is no discomfort—so can they start trying to conceive next month?

For ribavirin, this cannot be judged so simply. Data show that after multiple doses, its terminal half-life is long, which is why related drug labels and regulatory recommendations require continued contraception after stopping the drug, rather than immediately trying to conceive after discontinuation. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

It is especially important to note that medication use in both men and women needs to be considered.

At present, specific contraception duration requirements vary among countries and formulations. The information listed in the document shows that in China, 2023 warnings for systemic ribavirin formulations require women of childbearing age to use strict contraception during treatment and for at least 9 months after discontinuation; after male use, their female partners should use contraception for at least 6 months. Requirements for different ribavirin formulations in the United States also vary; some specify 9 months for women and 6 months for men, while others require both men and women to use contraception for 6 months after discontinuation. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

The reason for such caution is that ribavirin has clear evidence of animal embryotoxicity and teratogenicity. As for the risk in human pregnancy, current evidence is far less certain than that from animal studies. A pregnancy registry study once observed birth defects in exposed populations, but due to limitations such as insufficient sample size, it cannot be used to confirm a clear causal relationship in humans. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

Therefore, for people preparing for pregnancy, the key is not to panic after seeing these data, but to remember something more practical:

If either partner has recently used ribavirin, be sure to tell the reproductive doctor the specific drug name, dosage form, duration of use, and date of the last dose, and arrange preconception planning according to the corresponding drug label and the contraception period given by the doctor, rather than estimating on your own that “it should have been metabolized by now.”

This is especially true for those preparing to travel to Thailand for Thailand third-generation IVF. If the plan has already been decided, it is best to complete a review of medication history before entering the ovarian stimulation cycle, to avoid only remembering months later—during egg retrieval, fertilization, or even embryo culture—that related drugs were used.

II. Statins: Not Clearly “Teratogenic Drugs,” but You Should Not Stop Them on Your Own to Conceive

The second category that is easily misunderstood is statin lipid-lowering drugs, such as atorvastatin, rosuvastatin, simvastatin, etc.

For a long time, the relationship between statins and pregnancy was described in very absolute terms, so much so that some women on long-term medication to control blood lipids became very worried when preparing for pregnancy: “I took statins before—will it affect my child?”

In fact, related understanding has changed in recent years. In 2021, the U.S. FDA removed the previous uniform pregnancy contraindication for statins and emphasized that some pregnant women at high cardiovascular risk may have an individualized need to continue treatment. The research materials compiled in the document also show that some larger observational studies have not found a consistent association between statin exposure before pregnancy or in early pregnancy and a significantly increased overall risk of congenital malformations. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

However, this also should not be interpreted as “statins carry no risk at all, and you can take them freely during pregnancy.”

At this stage, a more reasonable approach is to distinguish populations and underlying diseases before deciding how to manage medications. For ordinary women who do not have high-risk cardiovascular disease and are planning pregnancy, it is usually possible to discuss preconception discontinuation with a doctor; the document gives a time frame of 1–3 months before pregnancy. However, for high-risk women such as those with familial hypercholesterolemia or a history of cardiovascular and cerebrovascular disease, the situation is completely different. The health risks of stopping medication without authorization may actually be greater, so cardiology and reproductive medicine departments need to evaluate the situation together. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

This point is equally important for those undergoing IVF: assisted reproduction does not make existing chronic diseases disappear, nor should long-term therapeutic drugs be stopped on one’s own in order to “give the eggs a clean environment.” What should really be done is to let the doctor know which medications you are taking before entering the ovarian stimulation and transfer plan, and then decide whether to stop, when to stop, and whether alternative treatment is needed based on maternal health risks and the pregnancy plan.

III. Can Recurrent Missed Miscarriage and Embryonic Abnormalities Be Directly Attributed to Past Medication Use?

This is where the boundaries most need to be made clear.

The causes of missed miscarriage are very complex, and a significant proportion are related to embryonic chromosomal abnormalities; other factors may include uterine structure, endocrine issues, antiphospholipid syndrome, and more. Therefore, one cannot work backward from the fact that a certain medication was taken before trying to conceive to conclude that “the missed miscarriage must have been caused by this drug.”

Even in cases of recurrent missed miscarriage, recurrent embryonic abnormalities, or multiple failed transfers, without sufficient evidence, one should not personally “convict” a particular medication.

Medications are better understood as one variable within the overall investigation system. Especially when common causes have already been systematically evaluated and both partners do have recent medication exposure, doctors can make further judgments by combining factors such as the drug’s reproductive toxicity evidence, dose, course of treatment, date of the last dose, and the sperm or egg formation cycle.

Some drugs may affect cell proliferation, metabolism, or early embryonic development, but from a pharmacological mechanism that is “possible” to actually proving that it caused a particular embryonic chromosomal abnormality or missed miscarriage, there is still a large evidentiary gap. Existing materials also clearly point out that for the judgment that “drug residues interfere with egg division, chromosome alignment, and early embryonic development,” direct human evidence is still limited at present. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

Therefore, if you have already experienced a missed miscarriage, the investigation should not become a search for a single culprit. Rather, it should be seen as a complete risk review: Have embryonic factors been evaluated? What is the condition of the uterine cavity? Do endocrine and coagulation-related issues need to be checked? What prescription drugs have both partners recently used? Have they taken lipid-lowering drugs, antiviral drugs, or other medications for chronic diseases long term?

Putting this information together is what gives it more clinical significance.

IV. Preparing for IVF: Why Is It Recommended to Also Organize the “Past-Year Medication History”?

Many families preparing for fertility treatment abroad or Thailand third-generation IVF carefully prepare AMH, sex hormones, ultrasound, semen analysis, previous egg retrieval records, and PGT reports, but few specifically organize a “medication list from the past year.”

In fact, this list is not complicated to put together, but it may help doctors discover information that is easily missed.

It is recommended that both partners recall and organize together: which prescription and long-term medications were taken in the past year, approximately when they started and stopped, and how long they were used; if medicine boxes, prescriptions, hospital records, or purchase records can still be found, they can be kept together. In particular, if ribavirin or other drugs with clear reproductive risk warnings have been used, the date of the last dose should be recorded clearly.

If there are conditions requiring long-term medication, such as hypertension, hyperlipidemia, diabetes, thyroid disease, mental health conditions, or immune system diseases, do not stop medication on your own just because you are preparing for pregnancy. The goal of medication management during preconception is never to have “not a single pill in the body,” but to choose, as much as possible, a regimen with clearer pregnancy risk and more reasonable management while ensuring maternal health.

For those who have already experienced recurrent missed miscarriage, embryonic chromosomal abnormalities, or multiple IVF failures, it is even more important to give the complete medication record to a reproductive doctor, rather than searching each drug name online and guessing the cause of the missed miscarriage based on a particular side effect. The document also emphasizes at the end that with recurrent unexplained missed miscarriage or embryonic chromosomal abnormalities, a complete medication list from the past year can be organized and given to a reproductive doctor for evaluation, but do not attribute the cause on your own. Can’t find the cause of missed miscarriage? Don’t overlook the medication history from the past year; focus on screening these two categories.

This is also a point that ThaiHo considers worth reminding families about when organizing preliminary materials and coordinating overseas medical accompaniment. When preparing for cross-border childbirth or fertility treatment abroad, in addition to organizing hormones, AMH, ultrasound, semen analysis, ovarian stimulation records, embryo reports, and previous transfer history, recent medication use can also be organized together, so that overseas doctors see not just a single test result, but a more complete reproductive and health record.

V. After a Missed Miscarriage, What Is Truly Worth Doing Is Not Guessing the Cause, but Filling In the Missing Information

After experiencing a missed miscarriage, the state people most easily fall into is constantly replaying: “Did I do something that day?” “Did I eat something?” “Was it some detail that harmed the embryo?”

But medically, missed miscarriage is often not that simple.

Ribavirin is a medication that requires strict attention during preconception; statins place more emphasis on individualized management based on cardiovascular risk. The two should not be conflated, and all past medication use should certainly not be understood as a risk factor causing missed miscarriage.

If ribavirin has been used recently, the contraception period after discontinuation should be strictly followed according to the specific formulation instructions and doctor’s requirements; if you are taking statins or other medications for chronic disease treatment, you should proactively tell your doctor before preparing for pregnancy, and the relevant specialty and reproductive doctor should jointly decide on subsequent medication, rather than stopping on your own.

For families preparing for IVF or Thailand third-generation IVF, or those who have already experienced recurrent missed miscarriage, embryonic abnormalities, or failed transfers, the approach to testing can also be broadened slightly: in addition to looking at today’s ovaries, embryos, and uterus, also look back at what the body has experienced and what medications were used over the past few months or even year.

What preconception truly requires is not the pursuit of a body with “no medications at all,” but rather identifying as early as possible the risks that can be recognized and managed before pregnancy begins.

ThaiHo can provide families planning to travel to Thailand for assisted reproduction with coordination for preliminary material organization, hospital appointments, doctor communication, translation accompaniment, pick-up and drop-off, and overseas medical accompaniment. In the process of preparing for fertility treatment abroad or cross-border childbirth, organizing past medical conditions, test results, IVF records, and recent medication history together is often more helpful for doctors to see the complete picture than focusing on a single AMH value, embryo grade, or failed outcome.